1 янв 1997 г. - Rituximab
Описание:
For use in patients with treatment-resistant, low-grade or follicular B-cell non-Hodgkin lymphoma (NHL), the Food and Drug Administration (FDA) approves rituximab, a monoclonal antibody.
Добавлено на ленту времени:
Дата: